Log In
Print
BCIQ
Print
Print this Print this
 

Kevetrin, thioureidobutyronitrile

  Manage Alerts
Collapse Summary General Information
Company Cellceutix Corp.
DescriptionSmall molecule protein kinase B (AKT; AKT1; PKB; PKBA) inhibitor and p53 activator that also acts as an alkylating agent and leukotriene B4 (LTB4) inhibitor with anti-angiogenic properties
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA) ; Leukotriene B4 (LTB4)
Mechanism of ActionAkt inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today